Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
GENESIS RESEARCH AND DEVELOPMENT CORPORATION LIMITED (GEN)
Delisted from ASX 30/08/2013
Former (or subsequent) names
Shareholder links
COMPANY WEBSITE:
REGISTRY:
Computershare, Level 3, 60 Carrington Street, Sydney NSW 2000
Tel : +61 (0)3 9415 4000​ or 1300 850 505 (within Australia)​
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail
Company details
Address: Level 15 PWC Tower, 188 Quay St Auckland, New Zealand
Tel: +64 9 373 5600 Fax: +64 9 373 5601
Date first listed: 22/09/2000
Company Secretary: Stephen Hall
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biotechnology company with core technical expertise in the fields of genomics and immunology - company seeks novel biologics which can be used as therapeutics or as targets for new drug therapies - primary disease targets are inflammatory or atopic disord
Tel: +64 9 373 5600 Fax: +64 9 373 5601
Date first listed: 22/09/2000
Company Secretary: Stephen Hall
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biotechnology company with core technical expertise in the fields of genomics and immunology - company seeks novel biologics which can be used as therapeutics or as targets for new drug therapies - primary disease targets are inflammatory or atopic disord
News & Events
| company deregistered today | 19/05/2015 |
| delisted following non-payment of annual listing fees in respect of the year ending 30 June 2014 | 30/08/2013 |
| we understand this company failed and has finally been delisted by ASX following non-payment of annual listing fees | 30/08/2013 |
| The company has not paid its annual fees in respect of the year ending 30 June 2014 but are already suspended from official quotation. In accordance with listing rule 16.5, entities that pay their annual listing fees on or after 23 August 2013must pay by bank cheque only. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm EST on Thursday 29 August 2013 will be removed from the official list with effect from the close of trading on Thursday 29 August 2013. | 23/08/2013 |
| releases Preliminary Final Report | 01/03/2013 |
| The securities of Genesis Research and Development Corporation Limited (the "Company") will be suspended from quotation immediately, under listing rule 17.3, following the Company" announcement today that it ""¦has insufficient funds to continue, even as a as a non-operating investment entity". Security Code: GEN | 13/11/2012 |
| the suspension of trading in the securities of Genesis Research and Development Corporation Limited (the "Company") will be lifted before the commencement of trading on Monday, 5 September 2011 in accordance with listing rule 17.8, following lodgement of the Company's Half Year Accounts for the period ended 30 June 2011 | 02/09/2011 |
| suspended from quotation following failure to lodge financial reports | 01/09/2011 |
ASX Announcements (courtesy of ASX)
Your comments
Company Updates
Post your comments here
Directors' on-market share transactions (last 5)
Directors & Executives (current)
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Aki von Roy | Chairman | |
| Joachim von Roy | Chairman, Independent Director | |
| Stephen Hall | CEO | 17/12/2004 |
| Ewe Lim | CFO | |
| Daniel Mahnert-Lueg | Independent Director | |
| Andy Gearing | Independent Director | 26/01/2006 |
| Steven Gillis | Independent Director | |
| Frankie Chen | Director | 09/08/2013 |
| Sharon Kwan | Director | 09/08/2013 |
| Gude Buer | Director | 19/12/2012 |
| Phi San Lam | Director | 09/08/2013 |
Date of first appointment, title may have changed.
Directors & Executives (former)
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Catherine Yan | Director | 12/07/2012 | 25/01/2013 |
| Tina Tan | Director | 30/11/2012 | 06/12/2012 |
Date of first appointment, title may have changed.